3) A 20‐gene signature of lymph node‐derived exhausted CD8+ T cells might forecast lymph node metastasis, and targeting HLA‐E‐KLRC1/KLRC2 signaling severs as a novel clinical therapeutic opportunity for GC. This evidence concerns the gene HLA-E and gastric cancer.